Voyager Therapeutics earnings were $25.9M for the trailing 12 months ending Sep 30, 2024, with -48.1% growth year over year. The latest VYGR earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$9.0M, down 10.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, VYGR reported annual earnings of $132.3M, with -385.1% growth. The next VYGR earnings date is Feb 26, 2025.
VYGR past earnings growth
How has VYGR's earnings growth performed historically?
Voyager Therapeutics Earnings Reports & History FAQ
What were Voyager Therapeutics's earnings last quarter?
On VYGR's earnings call on Invalid Date, Voyager Therapeutics (NASDAQ: VYGR) reported Q3 2024 earnings per share (EPS) of -$0.16, up 72.88% year over year. Total VYGR earnings for the quarter were -$9.04 million. In the same quarter last year, Voyager Therapeutics's earnings per share (EPS) was -$0.59.
The next VYGR earnings call is Invalid Date. Add VYGR to your watchlist to be reminded of Voyager Therapeutics's next earnings date.
What was VYGR's earnings growth in the past year?
As of Voyager Therapeutics's earnings date in Invalid Date, Voyager Therapeutics's earnings has grown -48.12% year over year. This is 69.81 percentage points lower than the US Biotechnology industry earnings growth rate of 21.69%. VYGR earnings in the past year totalled $25.88 million.
Is Voyager Therapeutics profitable or losing money?
As of the last Voyager Therapeutics earnings report, Voyager Therapeutics is currently profitable. Voyager Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $25.88 million, a 50.52% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.